[ORGANIZATION]
Lipfendra
Featured in 5 tracked stories · first seen
Situations
Inclisiran efficacy and evolving LDL cholesterol treatments
3 clusters · 9 sources · last updated
Latest: Cholesterol management: New study results and upcoming oral PCSK9 inhibitor
Research into the efficacy of inclisiran, a drug utilizing small interfering RNA (siRNA) technology to inhibit PCSK9 protein production, has demonstrated significant potential in reducing LDL cholesterol. An initial met
FDA approval of oral PCSK9 inhibitor Lipfendra
2 clusters · 4 sources · last updated
Latest: Lipfendra oral PCSK9 inhibitor receives FDA approval
The U.S. Food and Drug Administration (FDA) has approved enlicitide, marketed under the brand name Lipfendra, as the first oral PCSK9 inhibitor. This once-daily pill provides an alternative to the injectable versions of